Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma
Clinical trial NCT03313323 · UNKNOWN
Trial details
- NCT number
- NCT03313323
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-16
- Primary completion
- 2022-02-15
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.